(19)
(11) EP 3 471 672 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
11.11.2020 Bulletin 2020/46

(45) Mention of the grant of the patent:
23.09.2020 Bulletin 2020/39

(21) Application number: 17732005.8

(22) Date of filing: 14.06.2017
(51) International Patent Classification (IPC): 
A61F 9/00(2006.01)
 A61M 25/02(2006.01)
(86) International application number:
PCT/US2017/037368
(87) International publication number:
WO 2017/218615 (21.12.2017 Gazette 2017/51)

(54)

INJECTION DEVICE FOR SUBRETINAL DELIVERY OF THERAPEUTIC AGENT

INJEKTIONSVORRICHTUNG ZUR SUBRETINALEN FREISETZUNG EINES THERAPEUTIKUMS

DISPOSITIF D'INJECTION DESTINÉ À L'ADMINISTRATION SOUS-RÉTINIENNE D'UN AGENT THÉRAPEUTIQUE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 17.06.2016 US 201662351628 P
31.05.2017 US 201715609457

(43) Date of publication of application:
24.04.2019 Bulletin 2019/17

(73) Proprietor: Gyroscope Therapeutics Limited
Stevenage SG1 2FX (GB)

(72) Inventors:
  • PRICE, Daniel W.
    Cincinnati, Ohio 45242 (US)
  • OBERKIRCHER, Brendan J.
    Cincinnati, Ohio 45242 (US)
  • LEE, James G.
    Cincinnati, Ohio 45242 (US)
  • DENLINGER, Clinton
    Cincinnati, Ohio 45242 (US)
  • PRENGER, Daniel J.
    Cincinnati, Ohio 45241 (US)
  • KING, Geoffrey
    Cincinnati, Ohio 45241 (US)
  • UHLAND, Scott
    San Jose, California 95125 (US)
  • TSAI, Mark C.
    Horsham, Pennsylvania 19044 (US)
  • KEANE, Michael F.
    Horsham, Ohio 19044 (US)
  • KHAN, Isaac J.
    Horsham, Pennsylvania 19044 (US)
  • KO, Benjamin L.
    Cincinnati, Ohio 45202 (US)
  • MEYER, Thomas E.
    Cincinnati, Ohio 45202 (US)
  • TURNER, Denis P.
    San Clemente, California 92673 (US)

(74) Representative: Bettridge, Paul Sebastian 
Carpmaels & Ransford LLP One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A1-2013/157960
DE-A1- 2 051 239
US-A1- 2016 106 579
 WO-A2-2014/179698
US-A1- 2015 223 977
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).